Insys Therapeutics, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Insys Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2016-12-31 was -$1.00K.
- Insys Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2016-09-30 was $0.00.
- Insys Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2016-06-30 was $2.75M.
- Insys Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2016-03-31 was $13.35M.
- Insys Therapeutics, Inc. payments for repurchase of common stock for fiscal 2016 was $16.10M, a 2.19% decline from fiscal 2015.
- Insys Therapeutics, Inc. payments for repurchase of common stock for fiscal 2015 was $16.46M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2016-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $16.10M 10-K · filed 2019-03-13 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | |
| 2016-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | |
| 2016-03-31 | $13.35M 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $16.46M 10-K · filed 2018-03-12 |